{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:56:52Z","timestamp":1773140212328,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nrleng.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T23:03:32Z","timestamp":1757027012000},"page":"729-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune-mediated necrotizing myopathy: an emerging disorder"],"prefix":"10.1016","volume":"40","author":[{"given":"S.","family":"Portela-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Catalina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00f3pez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lozano Ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Soblechero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sola Vendrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e1nchez-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Mu\u00f1oz-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.nrleng.2025.09.004_bib0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Callaghan","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.nrleng.2025.09.004_bib0010","first-page":"290","article-title":"Autoantibodies in myositis","volume":"14","author":"Mchugh","year":"2018","journal-title":"Nat Publ Group."},{"issue":"1","key":"10.1016\/j.nrleng.2025.09.004_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med."},{"issue":"12","key":"10.1016\/j.nrleng.2025.09.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.nrleng.2025.09.004_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep."},{"issue":"4","key":"10.1016\/j.nrleng.2025.09.004_bib0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"10.1016\/j.nrleng.2025.09.004_bib0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0006-291X(82)91923-4","article-title":"A novel antibody wich precipitates 7.5S RNA is isolated from a patient with autoimmune disease","volume":"109","author":"Nakao","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.nrleng.2025.09.004_bib0040","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.nrleng.2025.09.004_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nrleng.2025.09.004_bib0050","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.nrleng.2025.09.004_bib0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00393-015-0029-3","article-title":"Immune-mediated necrotizing myopathy","volume":"75","author":"Bergua","year":"2016","journal-title":"Z Rheumatol."},{"issue":"1","key":"10.1016\/j.nrleng.2025.09.004_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord."},{"issue":"8","key":"10.1016\/j.nrleng.2025.09.004_bib0070","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain."},{"issue":"3","key":"10.1016\/j.nrleng.2025.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials - A literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke."},{"issue":"10","key":"10.1016\/j.nrleng.2025.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.nrleng.2025.09.004_bib0085","first-page":"150","article-title":"Anti-HMGCR autoantibodies in european patients with autoimmune necrotizing myopathies: Inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (United States)."},{"issue":"12","key":"10.1016\/j.nrleng.2025.09.004_bib0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol."},{"issue":"1","key":"10.1016\/j.nrleng.2025.09.004_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel","year":"2018","journal-title":"J Neuromuscul Dis."},{"issue":"9","key":"10.1016\/j.nrleng.2025.09.004_bib0100","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.nrleng.2025.09.004_bib0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mus.27435","article-title":"Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease","volume":"64","author":"Nicolau","year":"2021","journal-title":"Muscle Nerve."},{"issue":"1","key":"10.1016\/j.nrleng.2025.09.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"6","key":"10.1016\/j.nrleng.2025.09.004_bib0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0b013e32834b324b","article-title":"Necrotizing autoimmune myopathy","volume":"23","author":"Liang","year":"2011","journal-title":"Curr Opin Rheumatol."},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/practneurol-2017-001738","article-title":"Statin-related myopathies","volume":"18","author":"Hilton-Jones","year":"2018","journal-title":"Pract Neurol."},{"issue":"12","key":"10.1016\/j.nrleng.2025.09.004_bib0125","first-page":"223","article-title":"Statin-induced autoimmune necrotizing myositis\u2014A single-center case series highlighting this potentially life-threatening but treatable condition","volume":"10","author":"Tiniakou","year":"2020","journal-title":"Acta Myologica."},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4081\/cp.2020.1248","article-title":"Immune mediated necrotizing myopathy: a rare complication of statin therapy","volume":"10","author":"Abusharar","year":"2020","journal-title":"Clin Pract."},{"issue":"4","key":"10.1016\/j.nrleng.2025.09.004_bib0135","first-page":"257","article-title":"Immune-mediated necrotizing myopathy due to statins exposure","volume":"37","author":"Villa","year":"2018","journal-title":"Acta Myologica."},{"issue":"3","key":"10.1016\/j.nrleng.2025.09.004_bib0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun Rev."},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve."},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye","year":"2015","journal-title":"Muscle Nerve."},{"issue":"18","key":"10.1016\/j.nrleng.2025.09.004_bib0155","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory Muscle Diseases. Longo DL, editor","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nrleng.2025.09.004_bib0160","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa191","article-title":"Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: Role of electrical myotonia","volume":"2","author":"Triplett","year":"2020","journal-title":"Brain Commun."},{"issue":"4","key":"10.1016\/j.nrleng.2025.09.004_bib0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: Extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.nrleng.2025.09.004_bib0170","volume":"Vol. 20","author":"Pinal-Fernandez","year":"2018"},{"key":"10.1016\/j.nrleng.2025.09.004_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nrleng.2025.09.004_bib0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","article-title":"Spectrum of immune-mediated necrotizing myopathies and their treatments","author":"Pinal-fernandez","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"17","key":"10.1016\/j.nrleng.2025.09.004_bib0185","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen","year":"2015","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1016\/j.nrleng.2025.09.004_bib0190","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/rheumatology\/keaa158","article-title":"Plasmapheresis in recalcitrant anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody\u2013positive immune-mediated necrotizing myopathy: a case report","volume":"59","author":"L\u00f6tscher","year":"2020","journal-title":"Rheumatology."},{"issue":"6","key":"10.1016\/j.nrleng.2025.09.004_bib0195","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1002\/mus.26072","article-title":"Anti\u20133-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption","volume":"57","author":"Parikh","year":"2018","journal-title":"Muscle Nerve."},{"issue":"3","key":"10.1016\/j.nrleng.2025.09.004_bib0200","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/NXI.0000000000000096","article-title":"Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy","volume":"2","author":"Ramanathan","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"1","key":"10.1016\/j.nrleng.2025.09.004_bib0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","article-title":"Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review","volume":"52","author":"Tiniakou","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.nrleng.2025.09.004_bib0210","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"8","key":"10.1016\/j.nrleng.2025.09.004_bib0215","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.0000000000003006","article-title":"HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma","volume":"87","author":"Tsujikawa","year":"2016","journal-title":"Neurology."}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:15:52Z","timestamp":1760069752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580825000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2173580825000859"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.09.004","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated necrotizing myopathy: an emerging disorder","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2023.03.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}